QA and QC-Lecture I

Page 1: Overview of Pharmaceutical Microbiology Testing

Introduction to key concepts in pharmaceutical microbiology including:
- Good Laboratory Practices (GLP)
- Good Manufacturing Practices (GMP)
- Quality Control (QC) and Quality Assurance (QA)
Important testing methods include:
- Sterility Testing Methods
- Microbial Limits Testing
- Bioburden Determination
- Endotoxin (LAL) Testing
- Clean Room and Environmental Monitoring
- Detection and Identification of Unwanted Microorganisms
- Water Analysis
- Microbial Detection Systems
- Mycoplasma Detection and Testing

Definition: A set of principles intended to assure the quality and integrity of non-clinical laboratory studies.
History:
- First adopted in 1972 in Denmark and New Zealand.
- US FDA introduced GLP regulations in 1978-79.
Goals:
- Ensure preclinical testing is reliable and auditable for regulatory compliance.
Characteristics of GLPs:
- Measures to promote data reliability.
- Study protocols must be approved by management.
- Proper record keeping (dated, signed) for all procedures.
- Records maintained for at least two years, and five years if used for marketing permits.

Definition: Regulations ensuring manufactured products meet specified quality standards.
Applicability: Covers pharmaceuticals, medical devices, certain foods, and dietary supplements in the US.
Key Focus: Consumer safety by preventing contamination and ensuring product efficacy.
cGMP: Current Good Manufacturing Practices, highlighting the need for continual re-evaluation of practices to comply with evolving technology.

People: Employees must be trained on cGMPs and their responsibilities.
Products: Must be produced according to SOPs and tested for quality.
Processes: Well-designed and documented processes are required.
Procedures: Standardized and maintained throughout production.
Premises: Must be designed to minimize contamination risk; includes requirements for facilities and equipment.

GLPs: Used in pre-market research and product development, ensuring data integrity during testing.
GMPs: Applied during product manufacturing for quality assurance in batch testing and ingredient testing.
Distinction:
- GLPs focus on development, while GMPs focus on production.
- Examples provided of when each applies during product development and manufacturing phases.

Quality Assurance (QA): Encompasses the overall quality system; focused on confidence in quality.
Quality Control (QC): A subset of QA; focused on inspection and fulfillment of quality requirements.

Definition: Ensures confidence that quality requirements will be met.
Assurance extends internally to management and externally to customers and regulatory bodies.
Involves systematic activities to verify adherence to quality standards.

Definition: Ensures that specific quality requirements are met during manufacturing.
Emphasis on operational techniques and activities crucial for maintaining quality.

Sterility testing ensures products are free from viable microorganisms.
Definition: The absence of actively multiplying microorganisms is confirmed via specific culture media.
Results: Turbidity in broth media indicates contamination.
Applications: Required quality control test for sterile product release.

References: British Pharmacopoeia (BP) and USP on sterility media types.
Media types: Fluid Thioglycollate Medium (FTM) and Soybean Casein Digest Medium (SCD or TSB).
Key Pre-checks: Verify media sterility and growth support capacity before testing.

Aim: To evaluate media ability to support microorganism growth.
Procedure: Inoculate media with <100 cfu of challenge organisms; verify via concurrent viable plate counts.
Expected growth: Bacteria observed within 3 days, fungi within 5 days.

Aerobic bacteria strains suitable for testing:
- Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa
Anaerobic bacterium: Clostridium sporogenes
Fungi: Candida albicans and Aspergillus niger

Membrane Filtration Method: Utilized in sterile substance testing.
Direct Inoculation Method: Needed when preparing to test antimicrobial effects; neutralization required.

Process involves filtering the sample and cutting the membrane filter before incubation in broth or solid medium.

Procedure where medium is added into filtered sample and incubated to assess sterility.

Direct transfer of product into culture medium; no more than 10% of medium total volume.
Incubation periods: 14 days at specified temperatures for different media types.

Importance of validating the sterility test by introducing challenge organisms at the beginning of the incubation period.
General procedure methodology includes concurrent plate counts and growth promotion tests.

Desired outcome: Visible growth of challenge organisms in media within specified time frames.
Validation tests are necessary for substantiating the sterility results before interpretation.

Essential methods for documenting sterility tests, including raw data collection and specifications for growth promotion and media sterility tests.